logo-loader
AIM:IMM

ImmuPharma PLC

Receive alerts
Market:
AIM
Price
2.00 GBX
Day Change
7.55%
Market Cap:
£8.31 m
52 weeks high
3.80
52 weeks low
0.82

In brief

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics.

The company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives.

ImmuPharma's lead program, Lupuzor™, is a first-in-class autophagy immunomodulator for the treatment of lupus and preclinical analysis suggests therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Snapshot

  • ImmuPharma to take part in "premier partnering event"
  • Moderna, Legend Biotech advanced to the major league from the minors. But how do you spot a rookie company ready to move to the ‘show’?
  • ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments